Genomma Lab: EBITDA 2013-2018
This statistic shows the EBITDA (earnings before interest, taxes, depreciation, and amortization) of Genomma Lab from 2013 to 2018. Genomma Lab is one of the leading pharmaceutical and personal care companies in Mexico, with a high international presence. In 2018, the company reached an EBITDA of 2.38 billion Mexican pesos, down from 2.6 billion Mexican pesos recorded a year earlier.
